New biologic protects immunocompromised from COVID-19: studies
AstraZeneca’s long-acting monoclonal antibody can also be used to prevent disease progression, trials suggest.
AstraZeneca’s long-acting monoclonal antibody can also be used to prevent disease progression, trials suggest.
The number of individuals unable to receive any of the approved vaccines for medical reasons is miniscule, Professor Graeme Stewart says.
ADG talks to two leading vaccination experts to get the lowdown
The UK vaccinologist received a standing ovation at Wimbledon for her tireless efforts.
Patients choosing this device will need to learn a different technique for administering adrenaline.
Lee is a 74-year-old retiree who presents with a three-day history of an itchy rash on the forehead.
The suppression of the immune system during space flight is a well-documented phenomenon. During the Apollo missions in the ’60s and ’70s, for instance, many…
New study shows the faulty gene that causes ADA-SCID was successfully replaced in 48 out of 50 patients: NEJM.
Rani is a 16-year-old girl who presents with one week of rash affecting both legs.
Although the vaccine cavalry is finally coming over the hill, the need for better drugs to treat those with COVID-19 remains. Many drugs are being…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.